4-Antibody - Fully human Antibodies - freedom to target

Partnering

Hu-PAC™ an unencumbered and independent platform

The Hu-PAC™ platform is unencumbered by patent or licensing restrictions and can be used to develop antibodies against any antigen target.

There are a number of partnering options available with 4-Antibody: